Tags

Type your tag names separated by a space and hit enter

Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy.
Aust N Z J Obstet Gynaecol. 1986 Feb; 26(1):26-9.AN

Abstract

The results of a prospective trial to evaluate the use of diazoxide and labetalol given intravenously in the management of severe hypertensive disease in pregnancy are presented. Both drugs had an efficient hypotensive action. The reduction in blood pressure in the labetalol group was better controlled and this may be a factor influencing perinatal outcome. Because of the freedom of maternal and fetal side-effects, labetalol given by intravenous infusion is a more appropriate drug for use in the management of hypertensive crises occurring in pregnancy and labour.

Authors

Michael CA
No affiliation info available

MeSH

AdolescentAdultBirth WeightClinical Trials as TopicDelivery, ObstetricDiazoxideFemaleHumansHypertensionInfant, NewbornInfusions, ParenteralLabetalolPregnancyPregnancy Complications, CardiovascularProspective StudiesRandom Allocation

Pub Type(s)

Clinical Trial
Comparative Study
Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

3524548

Citation

Michael, C A.. "Intravenous Labetalol and Intravenous Diazoxide in Severe Hypertension Complicating Pregnancy." The Australian & New Zealand Journal of Obstetrics & Gynaecology, vol. 26, no. 1, 1986, pp. 26-9.
Michael CA. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy. Aust N Z J Obstet Gynaecol. 1986;26(1):26-9.
Michael, C. A. (1986). Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 26(1), 26-9.
Michael CA. Intravenous Labetalol and Intravenous Diazoxide in Severe Hypertension Complicating Pregnancy. Aust N Z J Obstet Gynaecol. 1986;26(1):26-9. PubMed PMID: 3524548.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy. A1 - Michael,C A, PY - 1986/2/1/pubmed PY - 1986/2/1/medline PY - 1986/2/1/entrez SP - 26 EP - 9 JF - The Australian & New Zealand journal of obstetrics & gynaecology JO - Aust N Z J Obstet Gynaecol VL - 26 IS - 1 N2 - The results of a prospective trial to evaluate the use of diazoxide and labetalol given intravenously in the management of severe hypertensive disease in pregnancy are presented. Both drugs had an efficient hypotensive action. The reduction in blood pressure in the labetalol group was better controlled and this may be a factor influencing perinatal outcome. Because of the freedom of maternal and fetal side-effects, labetalol given by intravenous infusion is a more appropriate drug for use in the management of hypertensive crises occurring in pregnancy and labour. SN - 0004-8666 UR - https://www.unboundmedicine.com/medline/citation/3524548/Intravenous_labetalol_and_intravenous_diazoxide_in_severe_hypertension_complicating_pregnancy_ DB - PRIME DP - Unbound Medicine ER -